Concordance between flow cytometry CLL scores

Int J Lab Hematol. 2021 Aug;43(4):743-751. doi: 10.1111/ijlh.13567. Epub 2021 May 4.

Abstract

Introduction: Multiple flow cytometry scores/diagnostic systems for the classification of leukemic lymphoproliferative disorders (LPD) have been published but few have been compared between them.

Patients and methods: We classified a cohort of leukemic LPD based on eleven published flow cytometry scores/diagnostic systems and compared their classification as chronic lymphocytic leukemia (CLL) or non-CLL LPD.

Results: 329 patients were included. Patients classified as CLL ranged from 46% to 73%, depending on the score/diagnostic system used. All eleven scores/diagnostic systems agreed in 184/324 (57%) of patients while in 58/324 (18%) at least two scores/diagnostic systems classified the patient differently (from the majority). Fleiss kappa was 0.74, but pairwise agreement was variable (Cohen's kappa: 0.48 to 0.87).

Conclusion: This study found a suboptimal agreement between published flow cytometry scores/diagnostic systems for the classification of LPD.

Keywords: CD43; chronic lymphocytic leukemia; flow cytometry; flow cytometry score; lymphoproliferative disorder.

MeSH terms

  • Antigens, CD / analysis
  • Biomarkers, Tumor / analysis
  • Flow Cytometry / methods*
  • Humans
  • Immunophenotyping
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
  • Lymphoproliferative Disorders / diagnosis

Substances

  • Antigens, CD
  • Biomarkers, Tumor